Progyny (PGNY) News Today $23.20 -0.68 (-2.85%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$23.56 +0.36 (+1.53%) As of 02/21/2025 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Progyny price target raised to $30 from $25 at BofAFebruary 19 at 2:45 PM | markets.businessinsider.comKornitzer Capital Management Inc. KS Sells 464,570 Shares of Progyny, Inc. (NASDAQ:PGNY)Kornitzer Capital Management Inc. KS decreased its position in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 47.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 511,931 shares of the company's stock aftFebruary 19 at 5:07 AM | marketbeat.comProgyny stock rises on expanded IVF accessFebruary 18, 2025 | investing.comIs Progyny, Inc.'s (NASDAQ:PGNY) Recent Stock Performance Tethered To Its Strong Fundamentals?February 18, 2025 | finance.yahoo.comAcuitas Investments LLC Takes $2.98 Million Position in Progyny, Inc. (NASDAQ:PGNY)Acuitas Investments LLC purchased a new position in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 172,732 shares of the company's sFebruary 18, 2025 | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Shares Bought by Baillie Gifford & Co.Baillie Gifford & Co. raised its position in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 52.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,332,690 shares of the company's stock after acquiring an additional 456,853 shares during the period. Baillie GifforFebruary 18, 2025 | marketbeat.comProgyny (PGNY) Projected to Post Earnings on TuesdayProgyny (NASDAQ:PGNY) will be releasing earnings before the market opens on Tuesday, February 25, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=318380)February 18, 2025 | marketbeat.comProgyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results ReportFebruary 13, 2025 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Progyny (PGNY) and Axsome Therapeutics (AXSM)February 11, 2025 | markets.businessinsider.comProgyny price target raised to $25 from $21 at BofAFebruary 11, 2025 | markets.businessinsider.comBank of America Raises Progyny (NASDAQ:PGNY) Price Target to $25.00Bank of America boosted their price objective on shares of Progyny from $21.00 to $25.00 and gave the stock a "buy" rating in a report on Tuesday.February 11, 2025 | marketbeat.comKuehn Law Encourages Investors of Progyny, Inc. to Contact Law FirmFebruary 10, 2025 | globenewswire.comVanderbilt University Acquires Shares of 14,730 Progyny, Inc. (NASDAQ:PGNY)Vanderbilt University bought a new position in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 14,730 shares of the company's stock, valued at approximately $254,000. SFebruary 6, 2025 | marketbeat.comGuidance Capital Inc. Invests $380,000 in Progyny, Inc. (NASDAQ:PGNY)Guidance Capital Inc. bought a new position in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 22,001 shares of the company's stock, valued at approximately $380,000. Several other largeFebruary 6, 2025 | marketbeat.comJanney Montgomery Scott LLC Buys Shares of 65,153 Progyny, Inc. (NASDAQ:PGNY)Janney Montgomery Scott LLC purchased a new position in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 65,153 shares of the company's stock, valued at approximately $1,124February 5, 2025 | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Stake Decreased by SG Americas Securities LLCSG Americas Securities LLC trimmed its holdings in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 33.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,613 shares of the company's stock after sellinJanuary 31, 2025 | marketbeat.comProgyny’s Strategic Acquisition Prompts Hold Rating Amid Short-Term Growth UncertaintyJanuary 30, 2025 | markets.businessinsider.comSt. Louis family benefits startup acquired by public companyJanuary 29, 2025 | bizjournals.comProgyny, Inc. (NASDAQ:PGNY) Receives Average Recommendation of "Hold" from AnalystsProgyny, Inc. (NASDAQ:PGNY - Get Free Report) has been given a consensus recommendation of "Hold" by the thirteen research firms that are covering the company, MarketBeat Ratings reports. Nine analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. TheJanuary 29, 2025 | marketbeat.comProgyny expands family support with BenefitBump acquisitionJanuary 28, 2025 | msn.comProgyny announces acquisition of BenefitBump, terms not disclosedJanuary 28, 2025 | markets.businessinsider.comProgyny (NASDAQ:PGNY) Price Target Raised to $23.00 at JPMorgan Chase & Co.JPMorgan Chase & Co. raised their target price on Progyny from $17.00 to $23.00 and gave the company a "neutral" rating in a research note on Tuesday.January 28, 2025 | marketbeat.comProgyny, Inc. Enhances Suite of Services with Acquisition of BenefitBumpJanuary 28, 2025 | globenewswire.comPacer Advisors Inc. Buys 1,183,558 Shares of Progyny, Inc. (NASDAQ:PGNY)Pacer Advisors Inc. grew its stake in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 47.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,676,200 shares of the company's stock after buying an additional 1,183,January 28, 2025 | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Holdings Raised by Fort Washington Investment Advisors Inc. OHFort Washington Investment Advisors Inc. OH lifted its position in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 90.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,467,780 sharesJanuary 23, 2025 | marketbeat.comWitness A Substantial Acquisition As DEBRA MORRIS Acquires Progyny Stock Options Worth $37KJanuary 23, 2025 | benzinga.comClear Harbor Asset Management LLC Invests $989,000 in Progyny, Inc. (NASDAQ:PGNY)Clear Harbor Asset Management LLC bought a new stake in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 57,335 shares of the cJanuary 22, 2025 | marketbeat.comProgyny shares surge 54% after November Fair Value signal flagged undervaluationJanuary 19, 2025 | msn.comProgyny appoints Morris to board of directorsJanuary 17, 2025 | markets.businessinsider.comProgyny appoints Debra Morris as new board memberJanuary 16, 2025 | msn.comProgyny adds healthcare veteran Debra Morris to boardJanuary 16, 2025 | msn.comProgyny Strengthens Leadership with New Director AppointmentJanuary 16, 2025 | tipranks.comProgyny Appoints Healthcare Veteran Debra Morris to Board of DirectorsJanuary 16, 2025 | globenewswire.comRep. Josh Gottheimer Sells Off Shares of Progyny, Inc. (NASDAQ:PGNY)Representative Josh Gottheimer (D-New Jersey) recently sold shares of Progyny, Inc. (NASDAQ:PGNY). In a filing disclosed on January 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in Progyny stock on December 6th. The trade occurred in the Representative's "MORGAN SJanuary 16, 2025 | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Shares Sold by JPMorgan Chase & Co.JPMorgan Chase & Co. lowered its position in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 87.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 368,076 shares of the company's stock after selling 2,660,5January 16, 2025 | marketbeat.comProgyny: The Growth Story Remains IntactJanuary 15, 2025 | seekingalpha.comProgyny FY2024 EPS Forecast Increased by Leerink PartnrsProgyny, Inc. (NASDAQ:PGNY - Free Report) - Equities researchers at Leerink Partnrs raised their FY2024 earnings estimates for shares of Progyny in a research note issued to investors on Monday, January 13th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings peJanuary 15, 2025 | marketbeat.comProgyny (PGNY) Gets a Hold from Truist FinancialJanuary 14, 2025 | markets.businessinsider.comLeibman Financial Services Inc. Purchases 31,872 Shares of Progyny, Inc. (NASDAQ:PGNY)Leibman Financial Services Inc. grew its position in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 100.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 63,509 shares of the company's stock after buying an additional 31,872 shaJanuary 14, 2025 | marketbeat.comProgyny sees Q4 results slightly above guidance ranges provided in NovemberJanuary 13, 2025 | markets.businessinsider.comProgyny’s Growth Potential and Strategic Partnerships Justify Buy RatingJanuary 13, 2025 | markets.businessinsider.comProgyny Stock Rises 7% on Improved 4Q OutlookJanuary 13, 2025 | marketwatch.comProgyny (NASDAQ:PGNY) Shares Gap Up - Here's WhyProgyny (NASDAQ:PGNY) Shares Gap Up - Time to Buy?January 13, 2025 | marketbeat.comProgyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare ConferenceJanuary 13, 2025 | markets.businessinsider.comCigna Healthcare Expands Access to Fertility and Family-Building Benefits and ServicesJanuary 13, 2025 | prnewswire.comProgyny (NASDAQ:PGNY) Trading Up 3.1% - Time to Buy?Progyny (NASDAQ:PGNY) Trading Up 3.1% - Time to Buy?January 8, 2025 | marketbeat.comInternational Assets Investment Management LLC Cuts Holdings in Progyny, Inc. (NASDAQ:PGNY)International Assets Investment Management LLC trimmed its position in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 94.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 152,964 shares oJanuary 8, 2025 | marketbeat.comKuehn Law Encourages Investors of Progyny, Inc. to Contact Law FirmJanuary 7, 2025 | prnewswire.comProgyny, Inc. (NASDAQ:PGNY) Given Consensus Recommendation of "Hold" by BrokeragesShares of Progyny, Inc. (NASDAQ:PGNY - Get Free Report) have received an average recommendation of "Hold" from the thirteen analysts that are currently covering the firm, Marketbeat reports. Nine analysts have rated the stock with a hold rating and four have assigned a buy rating to the company.January 4, 2025 | marketbeat.comThe Bottom Fishing Club: Progyny Reverses On Heavy Insider BuyingDecember 30, 2024 | seekingalpha.com Get Progyny News Delivered to You Automatically Sign up to receive the latest news and ratings for PGNY and its competitors with MarketBeat's FREE daily newsletter. Email Address PGNY Media Mentions By Week PGNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PGNY News Sentiment▼0.950.60▲Average Medical News Sentiment PGNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PGNY Articles This Week▼77▲PGNY Articles Average Week Get Progyny News Delivered to You Automatically Sign up to receive the latest news and ratings for PGNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Guardant Health News Option Care Health News RadNet News BrightSpring Health Services News Sotera Health News Surgery Partners News Veracyte News LifeStance Health Group News Privia Health Group News Concentra Group Holdings Parent News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PGNY) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Progyny, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Progyny With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PGNY Stock Alerts